— Know what they know.
Not Investment Advice

3183.T JPX

WIN-Partners Co., Ltd.
1W: -3.1% 1M: -2.7% 3M: +0.2% YTD: -13.3% 1Y: -8.8% 3Y: +24.8% 5Y: +45.1%
¥1,237.00 ($7.84)
-17.00 (-1.36%)
 
Weekly Expected Move ±2.1%
¥1186 ¥1211 ¥1237 ¥1263 ¥1288
JPX · Healthcare · Medical - Distribution · Tech Score Strong Sell · Power 30 · ¥34.0B mcap · 12M float · 0.145% daily turnover
Smart Money Score
Watch 0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap¥34.0B ($215.5M)
52W Range1175-1527
Volume35,600
Avg Volume16,831
Beta0.18
Dividend¥54.00
Analyst Ratings
No analyst coverage
Company Info
CEOHideumi Akizawa
Employees653
SectorHealthcare
IndustryMedical - Distribution
IPO Date2002-09-16
2-2-1 Kyobashi, Chuo-ku
Tokyo, TY 104-0031
JP
81 3 3548 0790
About WIN-Partners Co., Ltd.

Established in 1973 and headquartered in Tokyo, Japan, WIN-Partners Co., Ltd. leverages its subsidiaries to distribute a comprehensive range of medical devices to healthcare institutions, primarily across Japan. Its diverse product offerings include cutting-edge cardiovascular tools such as percutaneous transluminal coronary angioplasty balloon catheters, drug-eluting stents, and intravascular ultrasound catheters. The company also supplies devices for cardiac rhythm management, like pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters. Furthermore, WIN-Partners provides structural and peripheral vascular products, including stent grafts, transcatheter heart valves, mechanical heart valves, and various stents and embolic coils. Rounding out its portfolio are diabetes management systems such as insulin pumps and continuous glucose monitoring devices, in addition to magnetic resonance imaging equipment.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms